Skip to main content
. 2024 Jul 26;13(7):3783–3797. doi: 10.21037/tcr-24-747

Figure 5.

Figure 5

Pooled estimates of the network meta-analysis for all grades adverse events and anemia of grades 3 or 4. Pooled risk ratio (95% confidence intervals) for anemia of grade 3 or 4 (upper triangle) and all grades adverse events (lower triangle). IM, imatinib; DAS, dasatinib; NIL, nilotinib; BOS, bosutinib; RAD, radotinib; FLU, flumatinib; QD, quaque die; BID, bis in die.